Nov 18, 2020

The National Hemophilia Foundation would like to invite all healthcare providers, and anyone interested in rare bleeding disorders to watch a recorded webinar on Genetic Analysis and Other Diagnostic Tools for Rare Bleeding and Platelet Disorders. Originally presented ‘live’ during NHF’s Virtual Bleeding Disorder Conference in August, this comprehensive overview comprised the Second Annual Victor Grifols Roura Medical Preconference Symposium.

Made possible only through the generous support of Grifols, this symposium delves into the diagnosis and clinical management of patients with rare inherited bleeding and platelet disorders. 

The experienced faculty for this activity, all leading experts in their field, review the treatments currently available to manage bleeding in these patients and share significant advances being made to improve genetic diagnosis, including valuable insights on how to interpret rare platelet gene panels. Don’t miss this “rare” opportunity to learn more about the strides being made nationally to improve diagnosis and care for patients with these conditions.

The symposium is open access and free of cost.

Visit the NHF website to watch it today!

Moderator/Chair: Meera Chitlur, MD
Director, Hemophilia Treatment Center and Hemostasis Program, Children's Hospital of Michigan 

Amy Shapiro, MD
CEO and Co-Medical Director, Indiana Hemophilia and Thrombosis Center
Diane Nugent, MD
Medical Director, Pediatric Hematology, CHOC Children's, Center for Inherited Bleeding Disorders

Jorge A. Di Paola, MD
Division Chief, Pediatric Hematology & Oncology, Washington University School of Medicine at St. Louis

**This activity is not available for CME/CE credit